These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5373664)

  • 1. The effects of suramin and sodium salicylate on the morphological variation and virulence of two strains of Trypanosoma rhodesiense in mice.
    Vaughan JP
    Ann Trop Med Parasitol; 1969 Sep; 63(3):301-7. PubMed ID: 5373664
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of suramin on blood and tissue forms of Trypanosoma brucei and Trypanosoma rhodesiense.
    Woo P; Soltys MA
    Ann Trop Med Parasitol; 1971 Dec; 65(4):465-9. PubMed ID: 5145111
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological differences of two substrains of Trypanosoma brucei maintained by syringe passage in two different hosts.
    Soltys MA; Woo P
    Ann Trop Med Parasitol; 1970 Jun; 64(2):249-54. PubMed ID: 5491876
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug effects on the fine structure of Trypanosoma rhodesiense: suramin, tryparsamide and mapharside.
    Macadam RF; Williamson J
    Ann Trop Med Parasitol; 1974 Sep; 68(3):301-6. PubMed ID: 4280885
    [No Abstract]   [Full Text] [Related]  

  • 5. Suramin sensitivity of stocks of Trypanosoma evansi isolated in the Sudan.
    Abebe G; Jones TW; Boid R
    Trop Anim Health Prod; 1983 Aug; 15(3):151-2. PubMed ID: 6623646
    [No Abstract]   [Full Text] [Related]  

  • 6. [In vivo resistance to strains of Trypanosoma rhodesiense, Mozambique, 1985].
    Pérez Martín O; Lastre González M; Urban M; Shwalbach J
    Rev Cubana Med Trop; 1991; 43(3):189-93. PubMed ID: 9768188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental induction of suramin-resistance in cloned and uncloned stocks of Trypanosoma evansi using immunosuppressed and immunocompetent mice.
    Mutugi MW; Boid R; Luckins AG
    Trop Med Parasitol; 1994 Sep; 45(3):232-6. PubMed ID: 7899794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of Brazilian isolates of Trypanosoma evansi to suramin sodium: test in experimentally infected mice.
    Faccio L; Da Silva AS; Gressler LT; Tonin AA; Lazzarotto CR; Miletti LC; Monteiro SG
    Exp Parasitol; 2013 Jul; 134(3):309-12. PubMed ID: 23562880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro development of suramin-resistant clones of Trypanosoma evansi.
    Fang Y; Ye WX; Nei HY; Wang YL
    Acta Trop; 1994 Oct; 58(1):79-83. PubMed ID: 7863856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of Trypanosoma evansi to quinapyramine, suramin, stilbamidine and tryparsamide and analysis of cross-resistance.
    Gill BS
    Trans R Soc Trop Med Hyg; 1971; 65(3):352-7. PubMed ID: 4254332
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential effects of osmotic pressure and of suramin upon cultures of Trypanosoma congolense and T. rhodesiense.
    LEHMANN DL
    Ann Trop Med Parasitol; 1962 Apr; 56():1-3. PubMed ID: 14463760
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of infectivity after incubation in the presence of human blood allowing the differentiation of Trypanosoma brucei from Trypanosoma rhodesiense].
    Lapierre J; Hien TV; Le Prioux B
    Bull Soc Pathol Exot Filiales; 1974; 67(4):395-9. PubMed ID: 4480530
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistance to drug by different isolates Trypanosoma evansi in China.
    Zhou J; Shen J; Liao D; Zhou Y; Lin J
    Acta Trop; 2004 May; 90(3):271-5. PubMed ID: 15099814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth rates of suramin-sensitive and resistant Trypanosoma evansi.
    Mutugi MW; Boid R; Luckins AG
    Trop Anim Health Prod; 1996 May; 28(2):147-50. PubMed ID: 8809977
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigenic variation in clones of Trypanosoma brucei. II. The drug-sensitivities of variants of a clone and the antigenic relationships of trypanosomes before and after drug treatment.
    Gray AR
    Ann Trop Med Parasitol; 1966 Sep; 60(3):265-75. PubMed ID: 4226334
    [No Abstract]   [Full Text] [Related]  

  • 16. Innate lack of susceptibility of Ugandan Trypanosoma brucei rhodesiense to DL-alpha-difluoromethylornithine (DFMO).
    Iten M; Matovu E; Brun R; Kaminsky R
    Trop Med Parasitol; 1995 Sep; 46(3):190-4. PubMed ID: 8533023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth of Trypanosoma cruzi in vitro, unaffected by sodium salicylate.
    Duncanson FP; Abelmann WH; Pan C
    Ann Trop Med Parasitol; 1978 Dec; 72(6):577-8. PubMed ID: 367301
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of in vitro assay systems for the measurement of drug sensitivity of Trypanosoma evansi.
    Sutherland DV; Taylor AM; Ross CA
    Trop Med Parasitol; 1993 Sep; 44(3):208-12. PubMed ID: 8256099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond immune escape: a variant surface glycoprotein causes suramin resistance in Trypanosoma brucei.
    Wiedemar N; Graf FE; Zwyer M; Ndomba E; Kunz Renggli C; Cal M; Schmidt RS; Wenzler T; Mäser P
    Mol Microbiol; 2018 Jan; 107(1):57-67. PubMed ID: 28963732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suramin: with special reference to onchocerciasis.
    Hawking F
    Adv Pharmacol Chemother; 1978; 15():289-322. PubMed ID: 358805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.